Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
8%
Ph early_phase_1
1
8%
Ph not_applicable
8
67%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 1Safety & dosage
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(7)
Other(3)

Detailed Status

Completed7
unknown3
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (10.0%)
Phase 11 (10.0%)
N/A8 (80.0%)

Trials by Status

recruiting18%
unknown325%
completed758%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12